Phoenix, City of v. Purdue Pharma LP et al
Consolidated
Lead case: 1:17-md-02804
Lead case: 1:17-md-02804
Ohio Northern District Court | |
Judge: | Dan Aaron Polster |
Case #: | 1:18-op-45510 |
Nature of Suit | 470 Other Statutes - Racketeer Influenced and Corrupt Organizations |
Cause | 18:1961 Racketeering (RICO) Act |
Case Filed: | Apr 30, 2018 |
Case in other court: | Arizona, 2:18-cv-01150 |
Last checked: Friday Nov 08, 2019 5:41 PM EST |
Defendant
Purdue Pharma L.P.
|
|
Defendant
Johnson & Johnson
|
|
Defendant
Jonathan D. Sackler
|
|
Defendant
Kathe A. Sackler
|
|
Defendant
Mallinckrodt LLC
|
|
Defendant
Mallinckrodt PLC
|
|
Defendant
McKesson Corporation
|
Represented By
|
Defendant
Mortimer D.A. Sackler
|
|
Defendant
Mylan N.V. f/k/a Mylan Inc.
|
|
Defendant
Mylan Pharmaceuticals Inc.
|
|
Defendant
Noramco, Inc.
|
|
Defendant
Par Pharmaceutical Companies, Inc. f/k/a Par Pharmaceutical Holdings, Inc.
|
|
Defendant
Par Pharmaceutical, Inc.
|
|
Defendant
Purdue Pharma Inc.
|
|
Defendant
Janssen Pharmaceuticals Inc.
|
|
Defendant
Rhodes Pharmaceuticals L.P.
|
|
Defendant
Richard S. Sackler
|
|
Defendant
SpecGX LLC
|
|
Defendant
Teva Phamaceutical Industries Ltd
|
|
Defendant
Teva Pharmaceuticals USA, Inc.
|
|
Defendant
The Purdue Frederick Company, Inc.
|
|
Defendant
Theresa Sackler
|
|
Defendant
Trust for the Benefit of Members of the Raymond Sackler Family
|
|
Defendant
Walgreens Boots Alliance, Inc.
|
Represented By
|
Defendant
Walmart Inc. f/k/a Wal-Mart Stores, Inc.
|
|
Defendant
Warner Chilcott Company, LLC
|
|
Defendant
Watson Laboratories, Inc.
|
|
Defendant
West-Ward Pharmaceutical Corp.
|
|
Defendant
AmerisourceBergen Corporation
|
|
Defendant
Actavis Elizabeth LLC
|
|
Defendant
Actavis Kadian LLC
|
|
Defendant
Actavis LLC
|
|
Defendant
Actavis Laboratories FL, Inc.
|
|
Defendant
Actavis Laboratories UT, Inc.
|
|
Defendant
Actavis Mid Atlantic LLC
|
|
Defendant
Actavis Pharma, Inc. f/k/a Watson Pharma, Inc.
|
|
Defendant
Actavis South Atlantic LLC
|
|
Defendant
Actavis Totowa LLC
|
|
Defendant
Allergan Finance LLC f/k/a Actavis, Inc. f/k/a Watson Pharmaceuticals, Inc.
|
|
Defendant
Allergan Finance, LLC
|
|
Defendant
Allergan Sales, LLC
|
|
Defendant
Allergan USA, Inc.
|
|
Defendant
Allergan plc f/k/a Actavis plc
|
|
Defendant
AmerisourceBergen Drug Corporation
|
|
Defendant
Beverly Sackler
|
|
Defendant
CVS Health Corporation
|
|
Defendant
Cardinal Health, Inc.
|
|
Defendant
Cephalon Inc.
|
|
Defendant
David A. Sackler
|
|
Defendant
Endo Health Solutions Inc.
|
|
Defendant
Endo International plc
|
|
Defendant
Endo Pharmaceuticals, Inc.
|
|
Defendant
Hikma Pharmaceuticals plc
|
|
Defendant
Ilene Sackler Lefcourt
|
|
Defendant
Insys Therapeutics, Inc.
|
|
Plaintiff
Phoenix, City of
|
Represented By
|
Docket last updated: 10/15/2019 11:08 AM EDT |
Friday, April 13, 2018 | ||
1 | 1 174 pgs COMPLAINT. Filing fee received: $ 400.00, receipt number 0970-15383907 filed by Phoenix, City of. (Holm, Bradley)(MCO) [Transferred from azd on 4/30/2018.] | |
Att: 1 Civil Cover Sheet | ||
2 | 2 SUMMONS Submitted by Phoenix, City of. (Holm, Bradley) (MCO) [Transferred from azd on 4/30/2018.] | |
3 | 3 *Filing fee paid, receipt number 0970-15383907. This case has been assigned to the Honorable Deborah M Fine. All future pleadings or documents should bear the correct case number: CV 18-01150 PHX-DMF. Magistrate Election form attached. (MCO) *NEF regenerated on 4/16/2018 (CEI). [Transferred from azd on 4/30/2018.] | |
Monday, April 16, 2018 | ||
4 | 4 *NOTICE TO THE PARTIES - The Court is participating in the Mandatory Initial Discovery Pilot (MIDP) and this case is subject to that pilot. The key features and deadlines are set forth in the attached Notice which includes General Order 17-08. Also attached is a checklist for use by the parties. All parties must respond to the mandatory initial discovery requests set forth in the General Order before initiating any further discovery in this case. Please note: The discovery obligations in the General Order supersede the disclosures required by Rule 26(a)(1). Any party seeking affirmative relief must serve a copy of the attached documents (Notice to Parties, including General Order 17-08 and MIDP Checklist) on each new party when the Complaint, Counterclaim, Crossclaim, or Third-Party Complaint is served. (MCO) *NEF regenerated on 4/16/2018 (CEI). [Transferred from azd on 4/30/2018.] | |
5 | 5 *Summons Issued as to Purdue Pharma LP (Holm, Bradley) (MCO). *** IMPORTANT: When printing the summons, select "Document and stamps" or "Document and comments" for the seal to appear on the document. *Modified to reflect that only summons as to Purdue Pharma LP was issued on 4/16/2018, the remaining defendants' summons were issued on 4/18/2018 at *Doc. 6. on 4/18/2018 (MCO). [Transferred from azd on 4/30/2018.] | |
Wednesday, April 18, 2018 | ||
6 | 6 Summons Issued as to AmerisourceBergen Corporation, Cardinal Health Incorporated, Cephalon Incorporated, Endo Health Solutions Incorporated, Endo International PLC, Endo Pharmaceuticals Incorporated, Insys Therapeutics Incorporated, Janssen Pharmaceuticals Incorporated, Mallinckrodt LLC, Mallinckrodt PLC, McKesson Corporation, Teva Pharmaceutical Industries Limited, Teva Pharmaceuticals USA Incorporated. (Holm, Bradley) (MCO). *** IMPORTANT: When printing the summons, select "Document and stamps" or "Document and comments" for the seal to appear on the document. [Transferred from azd on 4/30/2018.] | |
Monday, April 30, 2018 | ||
Case Transferred to the Northern District of Ohio via electronic transfer. This is a TEXT ENTRY ONLY. There is no PDF document associated with this entry. (MAP) [Transferred from azd on 4/30/2018.] | ||
7 | 7 CERTIFIED MDL TRANSFER ORDER (CTO-25) Transferring Case to the Northern District of Ohio Re MDL-2804. (MAP) [Transferred from azd on 4/30/2018.] | |
8 | 8 CASE TRANSFERRED IN from District of Arizona. Case number 2:18-cv-01150. Original file, certified copy of transfer order and docket sheet received. |